Walid Fakhouri

Affiliations: 
2005-2009 Biochemistry Michigan State University, East Lansing, MI 
Google:
"Walid Fakhouri"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Zhang A, Aslam H, Sharma N, et al. (2021) Conservation of Epithelial-to-Mesenchymal Transition Process in Neural Crest Cells and Metastatic Cancer. Cells, Tissues, Organs. 1-22
Perrone V, Losi S, Rogai V, et al. (2021) Treatment Patterns and Pharmacoutilization in Patients Affected by Rheumatoid Arthritis in Italian Settings. International Journal of Environmental Research and Public Health. 18
Fakhouri W, Sapin C, Holzkaemper T, et al. (2021) Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis. Advances in Therapy
Caporali R, Fakhouri WKH, Nicolay C, et al. (2020) New Rheumatoid Arthritis Treatments for 'Old' Patients: Results of a Systematic Review. Advances in Therapy
Fakhouri W, Wang X, de La Torre I, et al. (2020) A Network Meta-Analysis to Compare Effectiveness of Baricitinib and Other Treatments in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate. Journal of Health Economics and Outcomes Research. 7: 10-23
Perrone V, Losi S, Rogai V, et al. (2020) Real-World Analysis of Therapeutic Patterns in Patients Affected by Rheumatoid Arthritis in Italy: A Focus on Baricitinib. Rheumatology and Therapy
Van De Laar CJ, Oude Voshaar MAH, Fakhouri WKH, et al. (2020) Cost-Effectiveness of a JAK1/JAK2 Inhibitor vs a Biologic Disease-Modifying Antirheumatic Drug (bDMARD) in a Treat-to-Target Strategy for Rheumatoid Arthritis. Clinicoeconomics and Outcomes Research : Ceor. 12: 213-222
Schlueter M, Rouse P, Pitcher A, et al. (2020) A modeling framework for the economic evaluation of baricitinib in moderate-to-severe rheumatoid arthritis. Expert Review of Pharmacoeconomics & Outcomes Research. 1-8
Ten Klooster PM, Versteeg LGA, Oude Voshaar MAH, et al. (2019) Radiographic progression can still occur in individual patients with low or moderate disease activity in the current treat-to-target paradigm: real-world data from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry. Arthritis Research & Therapy. 21: 237
Wehr C, Cruz G, Young S, et al. (2019) An Insight into Acute Pericoronitis and the Need for an Evidence-Based Standard of Care. Dentistry Journal. 7
See more...